5 Biotech Penny Stocks to Buy Now

4. Entera Bio Ltd. (NASDAQ:ENTX)

Number of Hedge Fund Holders: 5

Entera Bio Ltd. (NASDAQ:ENTX) is a biopharma firm that concentrates on the development of orally-delivered therapeutics. In early October, the company had shared positive mid-stage data from a study of EB613, a drug for the treatment of osteoporosis. 

Entera Bio Ltd. (NASDAQ:ENTX) posted earnings for the first half of the year in August, reporting a revenue of $0.27 million, up over 170% compared to the revenue over the same period last year and beating estimates by $0.2 million. 

Among the hedge funds being tracked by Insider Monkey, New York-based firm Knoll Capital Management is a leading shareholder in Entera Bio Ltd. (NASDAQ:ENTX) with 2.4 million shares worth more than 11 million.